Infants younger than one year of age with RhabdomyosarcTJmrr'appear to have worse prognosis compared to older children due partly to high rates of local failure. We report a 4 months old infant with orbital rhabdomyosarcoma with poor outcome.. Reluctance to use aggressive local control measures and suboptimal chemotherapy dosing are significant contributory factors. Cal 1 is made for need for more studies to determine appropriate local therapy in infants with rhabdomyosarcoma
Li-Ying Tang,1 Mou-Xin Zhang,2 Di-Han Lu,3 Yong-Xiong Chen,1 Zu-Guo Liu,1,2 San-Gang Wu4 1Eye Instit...
Rhabdomyosarcoma (RMS) is a highly malignant tumor and is one of the few life-threatening diseases t...
Background: Although rhabdomyosarcoma (RMS) is a rare tumor among the entire group of mesenchymal ma...
Rhabdomyosacoma, as a medical condition, observed in a four month old infant at a Zimbabwe hospital....
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Rhabdomyosarcoma is the most frequent mesenchymal tumor in children, composed of cells with histopat...
Rhabdomyosarcoma (RMS) is the most common primary malignant tumor of the orbit in childhood. The ave...
Background. Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Fifty percent...
Background: Infants (<12 months) with rhabdomyosarcoma have historically had poorer outcome than the...
Rhabdomyosarcoma is the most common primary malignancy in children. It constitutes a therapeutic eme...
BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood, but occurs i...
Orbital rhabdomyosarcoma is mesenchymal tumor, presents 10-20% of all rhabdomyosarcoma are usually d...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Fifty-one children (median age: 4.5 years; 4 months-16 years) diagnosed with rhabdomyosarcoma were t...
Li-Ying Tang,1 Mou-Xin Zhang,2 Di-Han Lu,3 Yong-Xiong Chen,1 Zu-Guo Liu,1,2 San-Gang Wu4 1Eye Instit...
Rhabdomyosarcoma (RMS) is a highly malignant tumor and is one of the few life-threatening diseases t...
Background: Although rhabdomyosarcoma (RMS) is a rare tumor among the entire group of mesenchymal ma...
Rhabdomyosacoma, as a medical condition, observed in a four month old infant at a Zimbabwe hospital....
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
BACKGROUND: The management of rhabdomyosarcoma (RMS) in patients age < 1 year is particularly proble...
Rhabdomyosarcoma is the most frequent mesenchymal tumor in children, composed of cells with histopat...
Rhabdomyosarcoma (RMS) is the most common primary malignant tumor of the orbit in childhood. The ave...
Background. Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Fifty percent...
Background: Infants (<12 months) with rhabdomyosarcoma have historically had poorer outcome than the...
Rhabdomyosarcoma is the most common primary malignancy in children. It constitutes a therapeutic eme...
BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood, but occurs i...
Orbital rhabdomyosarcoma is mesenchymal tumor, presents 10-20% of all rhabdomyosarcoma are usually d...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Fifty-one children (median age: 4.5 years; 4 months-16 years) diagnosed with rhabdomyosarcoma were t...
Li-Ying Tang,1 Mou-Xin Zhang,2 Di-Han Lu,3 Yong-Xiong Chen,1 Zu-Guo Liu,1,2 San-Gang Wu4 1Eye Instit...
Rhabdomyosarcoma (RMS) is a highly malignant tumor and is one of the few life-threatening diseases t...
Background: Although rhabdomyosarcoma (RMS) is a rare tumor among the entire group of mesenchymal ma...